Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tonya J Webb

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Investigation|September 15, 2021
Inclusion criteria: how NK cells gain access to T cellsTonya J Webb
Frontiers in Biology|December 25, 2012
Boosting the Immune Response: The Use of iNKT cell ligands as vaccine adjuvantsPriyanka Subrahmanyam, Tonya J Webb
Translational Research : the Journal of Laboratory and Clinical Medicine|June 27, 2017
Chimeric antigen receptor-engineered natural killer and natural killer T cells for cancer immunotherapyDominique Bollino, Tonya J Webb
Journal of Immunology (Baltimore, Md. : 1950)|January 12, 2022
Effective Barriers: The Role of NKT Cells and Innate Lymphoid Cells in the GutCristiana Cairo, Tonya J Webb
Translational Cancer Research|September 23, 2017
Targeted attack: mechanisms by which ovarian cancers suppress the immune systemIrina V Tiper, Tonya J Webb
Molecular and Cellular Pharmacology|March 21, 2014
The Roles of Radiotherapy and Immunotherapy for the Treatment of LymphomaAmy S Kimball, Tonya J Webb
Cancer Immunology, Immunotherapy : CII|September 12, 2016
Histone deacetylase inhibitors enhance CD1d-dependent NKT cell responses to lymphomaIrina V Tiper, Tonya J Webb
Immunity|March 21, 2019
Defining Barriers that Impede ChoicesTonya J Webb, Amy S Weinmann
Molecular Immunology|December 4, 2018
The ins and outs of type I iNKT cell developmentSusannah C Shissler, Tonya J Webb
Frontiers in Immunology|November 1, 2023
Novel lipid antigens for NKT cells in cancerMichael S Lee, Tonya J Webb
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Investigation|September 15, 2021
Inclusion criteria: how NK cells gain access to T cellsTonya J Webb
Frontiers in Biology|December 25, 2012
Boosting the Immune Response: The Use of iNKT cell ligands as vaccine adjuvantsPriyanka Subrahmanyam, Tonya J Webb
Translational Research : the Journal of Laboratory and Clinical Medicine|June 27, 2017
Chimeric antigen receptor-engineered natural killer and natural killer T cells for cancer immunotherapyDominique Bollino, Tonya J Webb
Journal of Immunology (Baltimore, Md. : 1950)|January 12, 2022
Effective Barriers: The Role of NKT Cells and Innate Lymphoid Cells in the GutCristiana Cairo, Tonya J Webb
Translational Cancer Research|September 23, 2017
Targeted attack: mechanisms by which ovarian cancers suppress the immune systemIrina V Tiper, Tonya J Webb
Molecular and Cellular Pharmacology|March 21, 2014
The Roles of Radiotherapy and Immunotherapy for the Treatment of LymphomaAmy S Kimball, Tonya J Webb
Cancer Immunology, Immunotherapy : CII|September 12, 2016
Histone deacetylase inhibitors enhance CD1d-dependent NKT cell responses to lymphomaIrina V Tiper, Tonya J Webb
Immunity|March 21, 2019
Defining Barriers that Impede ChoicesTonya J Webb, Amy S Weinmann
Molecular Immunology|December 4, 2018
The ins and outs of type I iNKT cell developmentSusannah C Shissler, Tonya J Webb
Frontiers in Immunology|November 1, 2023
Novel lipid antigens for NKT cells in cancerMichael S Lee, Tonya J Webb
Pageof 6